Encoded Therapeutics Revenue and Competitors

Location

$239.1M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Encoded Therapeutics's estimated annual revenue is currently $43.8M per year.(i)
  • Encoded Therapeutics's estimated revenue per employee is $193,750
  • Encoded Therapeutics's total funding is $239.1M.

Employee Data

  • Encoded Therapeutics has 226 Employees.(i)
  • Encoded Therapeutics grew their employee count by 16% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M50%N/AN/A
#4
$2.3M129%N/AN/A
#5
$1.4M8-20%N/AN/A
#6
N/A740%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.5M129%N/AN/A
Add Company

Encoded Therapeutics Inc. is a biotechnology company advancing precision medicines for a broad range of genetic disorders. Our mission is to unlock new opportunities for viral gene therapy through genomics-driven discovery. We focus on delivering life-changing advances for individuals with genetic disorders not addressable with current approaches. For more information, please visit www.Encoded.com

keywords:N/A

$239.1M

Total Funding

226

Number of Employees

$43.8M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Encoded Therapeutics's People

NameTitleEmail/Phone
1
Senior Human Resources GeneralistReveal Email/Phone
2
Clinical Program ManagerReveal Email/Phone
3
Scientist IIReveal Email/Phone
4
Associate DirectorReveal Email/Phone
5
VP MSAT and ManufacturingReveal Email/Phone
6
VP, EngineeringReveal Email/Phone
7
VP Clinical and Medical Affairs; Head the Medical OfficeReveal Email/Phone
8
Director, Supply ChainReveal Email/Phone
9
Director Molecular and Cellular PharmacologyReveal Email/Phone
10
MSAT EngineerReveal Email/Phone

Encoded Therapeutics News

2022-04-17 - Discovery of unusual dimeric piperazyl cyclopeptides ...

Discovery of unusual dimeric piperazyl cyclopeptides encoded by a ... of humankind's most important and enduring sources of therapeutics.

2020-07-27 - Encoded Therapeutics Closes $135 Million In Series D Funding

Precision gene therapy company Encoded Therapeutics announced it has raised $135 million in an oversubscribed Series D round of funding Precision gene therapy company Encoded Therapeutics, Inc. (Encoded) announced it has raised $135 million in an oversubscribed Series D round of funding. And th ...

2020-07-23 - Encoded Therapeutics Raises $135M in Series D Financing

Encoded Therapeutics, Inc., a South Francisco, Calif.-based precision gene therapy company, raised $135m in Series D financing. The round was led by GV (formerly Google Ventures) with participation from Matrix Capital Management, ARCH Venture Partners, Illumina Ventures, RTW Investments, Boxer ...

2020-07-22 - Encoded Therapeutics Announces $135 Million Series D Financing to Support First Clinical Trials in SCN1A+ Dravet Syndrome and Advance Preclinical Pipeline of Gene Therapies for Debilitating Neurological Disorders

SOUTH SAN FRANCISCO, Calif., July 22, 2020 /PRNewswire/ -- Encoded Therapeutics, Inc. (Encoded), a precision gene therapy company, today announced it has raised $135 million in an oversubscribed Series D financing. The company also announced that its lead asset, ETX101, was granted Orphan Drug D ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$34.2M227-22%$35M
#2
$27.8M2377%N/A
#3
$10.1M246-13%N/A
#4
$48.6M251-4%$65M
#5
$147.3M261-2%$192.5M